{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:02:11Z","timestamp":1792119731655,"version":"4.4.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,4]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>Telomerase reverse transcriptase (<jats:italic toggle=\"yes\">TERT<\/jats:italic>) promoter mutations are commonly found in malignant melanomas but rare in melanocytic nevi. To assess its potential diagnostic utility for the distinction of melanoma from nevus, we determined the <jats:italic toggle=\"yes\">TERT<\/jats:italic> promoter mutation status of 86 primary melanomas, 72 melanocytic nevi, and 40 diagnostically problematic melanocytic proliferations. Of the 86 melanomas, 67 (77.9%) were <jats:italic toggle=\"yes\">TERT<\/jats:italic>-positive, defined as harboring a hotspot <jats:italic toggle=\"yes\">TERT<\/jats:italic> promoter mutation at positions -124C&gt;T, -124_125CC&gt;TT, -138_139CC&gt;TT, or -146C&gt;T. Of the 72 nevi, only 1 (1.4%) was <jats:italic toggle=\"yes\">TERT<\/jats:italic>-positive. Of the 40 diagnostically uncertain melanocytic proliferations, 2 (5.0%) were <jats:italic toggle=\"yes\">TERT<\/jats:italic>-positive. <jats:italic toggle=\"yes\">TERT<\/jats:italic> positivity as a test for melanoma versus nevus had an accuracy of 87.3% [95% confidence interval (CI), 81.1\u201392.1], a sensitivity of 77.9% (95% CI, 68.9\u201385.4), a specificity of 98.6% (95% CI, 95.8\u2013100), a positive predictive value of 98.5% (95% CI, 95.6\u2013100), and a negative predictive value of 78.9% (95% CI, 72.6\u201385.4). Our results indicate that hotspot <jats:italic toggle=\"yes\">TERT<\/jats:italic> promoter mutation status may be a useful ancillary parameter for the diagnosis of melanoma. In particular, the high specificity of these mutations for melanoma indicates the presence of a <jats:italic toggle=\"yes\">TERT<\/jats:italic> promoter mutation in a melanocytic neoplasm associated with diagnostic controversy, or uncertainty should increase concern for a melanoma.<\/jats:p>","DOI":"10.1097\/dad.0000000000001259","type":"journal-article","created":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T19:26:45Z","timestamp":1537990005000},"page":"264-272","source":"Crossref","is-referenced-by-count":46,"title":["Utility of TERT Promoter Mutations for Cutaneous Primary Melanoma Diagnosis"],"prefix":"10.1097","volume":"41","author":[{"given":"Nancy E.","family":"Thomas","sequence":"first","affiliation":[{"name":"Department of Dermatology, School of Medicine, University of North Carolina, Chapel Hill, NC;"},{"name":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon N.","family":"Edmiston","sequence":"additional","affiliation":[{"name":"Department of Dermatology, School of Medicine, University of North Carolina, Chapel Hill, NC;"},{"name":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihsuan S.","family":"Tsai","sequence":"additional","affiliation":[{"name":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel S.","family":"Parker","sequence":"additional","affiliation":[{"name":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC;"},{"name":"Genetics, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul B.","family":"Googe","sequence":"additional","affiliation":[{"name":"Department of Dermatology, School of Medicine, University of North Carolina, Chapel Hill, NC;"},{"name":"Pathology and Laboratory Medicine, School of Medicine, University of North Carolina, Chapel Hill, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus J.","family":"Busam","sequence":"additional","affiliation":[{"name":"Department of Pathology, Memorial Sloan-Kettering Cancer Center, Manhattan, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glynis A.","family":"Scott","sequence":"additional","affiliation":[{"name":"Dermatology, and"},{"name":"Pathology and Laboratory Medicine, University of Rochester School of Medicine, Rochester, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C.","family":"Zedek","sequence":"additional","affiliation":[{"name":"Department of Dermatology, School of Medicine, University of North Carolina, Chapel Hill, NC;"},{"name":"Pathology and Laboratory Medicine, School of Medicine, University of North Carolina, Chapel Hill, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloise A.","family":"Parrish","sequence":"additional","affiliation":[{"name":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglin","family":"Hao","sequence":"additional","affiliation":[{"name":"Department of Dermatology, School of Medicine, University of North Carolina, Chapel Hill, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel A.","family":"Slater","sequence":"additional","affiliation":[{"name":"Department of Dermatology, School of Medicine, University of North Carolina, Chapel Hill, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle V.","family":"Pearlstein","sequence":"additional","affiliation":[{"name":"Department of Dermatology, School of Medicine, University of North Carolina, Chapel Hill, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill S.","family":"Frank","sequence":"additional","affiliation":[{"name":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC;"},{"name":"Department of Surgery, School of Medicine, University of North Carolina, Chapel Hill, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei Fen","family":"Kuan","sequence":"additional","affiliation":[{"name":"Department of Applied Mathematics and Statistics, State University of New York, Stony Brook, NY; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Ollila","sequence":"additional","affiliation":[{"name":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC;"},{"name":"Department of Surgery, School of Medicine, University of North Carolina, Chapel Hill, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Conway","sequence":"additional","affiliation":[{"name":"Department of Dermatology, School of Medicine, University of North Carolina, Chapel Hill, NC;"},{"name":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC;"},{"name":"Department of Epidemiology, School of Public Health, University of North Carolina, Chapel Hill, NC."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230908","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1126\/science.1229259","article-title":"Highly recurrent TERT promoter mutations in human melanoma","volume":"339","author":"Huang","year":"2013","journal-title":"Science."},{"key":"R2-20230908","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1230062","article-title":"TERT promoter mutations in familial and sporadic melanoma","volume":"339","author":"Horn","year":"2013","journal-title":"Science."},{"key":"R3-20230908","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/CMR.0000000000000048","article-title":"Melanomas of unknown primary frequently harbor TERT-promoter mutations","volume":"24","author":"Egberts","year":"2014","journal-title":"Melanoma Res."},{"key":"R4-20230908","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1038\/ncomms4401","article-title":"Telomerase reverse transcriptase promoter mutations in primary cutaneous melanoma","volume":"5","author":"Heidenreich","year":"2014","journal-title":"Nat Commun."},{"key":"R5-20230908","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nature22071","article-title":"Whole-genome landscapes of major melanoma subtypes","volume":"545","author":"Hayward","year":"2017","journal-title":"Nature."},{"key":"R6-20230908","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nm.4333","article-title":"Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients","volume":"23","author":"Zehir","year":"2017","journal-title":"Nat Med."},{"key":"R7-20230908","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1038\/jid.2014.163","article-title":"TERT promoter mutations in skin cancer: the effects of sun exposure and x-irradiation","volume":"134","author":"Populo","year":"2014","journal-title":"J Invest Dermatol."},{"key":"R8-20230908","doi-asserted-by":"crossref","first-page":"pii: dju246","DOI":"10.1093\/jnci\/dju246","article-title":"TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma","volume":"106","author":"Griewank","year":"2014","journal-title":"J Natl Cancer Inst."},{"key":"R9-20230908","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/CMR.0000000000000446","article-title":"Telomerase reverse transcriptase promoter mutations and solar elastosis in cutaneous melanoma","volume":"28","author":"Lade-Keller","year":"2018","journal-title":"Melanoma Res."},{"key":"R10-20230908","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00432-016-2322-1","article-title":"Distribution of TERT promoter mutations in primary and metastatic melanomas in Austrian patients","volume":"143","author":"Ofner","year":"2017","journal-title":"J Cancer Res Clin Oncol."},{"key":"R11-20230908","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.ejca.2015.03.010","article-title":"Recurrent TERT promoter mutations identified in a large-scale study of multiple tumour types are associated with increased TERT expression and telomerase activation","volume":"51","author":"Huang","year":"2015","journal-title":"Eur J Cancer."},{"key":"R12-20230908","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/ijc.30042","article-title":"TERT promoter mutations in melanoma survival","volume":"139","author":"Nagore","year":"2016","journal-title":"Int J Cancer."},{"key":"R13-20230908","doi-asserted-by":"crossref","first-page":"11200","DOI":"10.1038\/srep11200","article-title":"TERT promoter mutations are predictive of aggressive clinical behavior in patients with spitzoid melanocytic neoplasms","volume":"5","author":"Lee","year":"2015","journal-title":"Sci Rep."},{"key":"R14-20230908","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1038\/ncomms3185","article-title":"Frequency of TERT promoter mutations in human cancers","volume":"4","author":"Vinagre","year":"2013","journal-title":"Nat Commun."},{"key":"R15-20230908","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/pcmr.12565","article-title":"TERT promoter mutations are not always associated with poor prognosis in atypical spitzoid tumors","volume":"30","author":"Requena","year":"2017","journal-title":"Pigment Cell Melanoma Res."},{"key":"R16-20230908","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J Clin Oncol."},{"key":"R17-20230908","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/j.0022-202X.2004.22523.x","article-title":"Tandem BRAF mutations in primary invasive melanomas","volume":"122","author":"Thomas","year":"2004","journal-title":"J Invest Dermatol."},{"key":"R18-20230908","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1158\/1055-9965.EPI-06-1038","article-title":"Number of nevi and early-life ambient UV exposure are associated with BRAF-mutant melanoma","volume":"16","author":"Thomas","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"R19-20230908","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/modpathol.2013.167","article-title":"Mutations of the TERT promoter are common in basal cell carcinoma and squamous cell carcinoma","volume":"27","author":"Scott","year":"2014","journal-title":"Mod Pathol."},{"key":"R20-20230908","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3322\/caac.21409","article-title":"Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA Cancer J Clin."},{"key":"R21-20230908","doi-asserted-by":"crossref","first-page":"137","DOI":"10.5694\/mja17.00278","article-title":"Updated evidence-based clinical practice guidelines for the diagnosis and management of melanoma: definitive excision margins for primary cutaneous melanoma","volume":"208","author":"Sladden","year":"2018","journal-title":"Med J Aust."},{"key":"R22-20230908","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/pcmr.12441","article-title":"TERT promoter mutations associate with fast-growing melanoma","volume":"29","author":"Nagore","year":"2016","journal-title":"Pigment Cell Melanoma Res."},{"key":"R23-20230908","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jmoldx.2015.07.010","article-title":"Varying mutational alterations in multiple primary melanomas","volume":"18","author":"Egberts","year":"2016","journal-title":"J Mol Diagn."},{"key":"R24-20230908","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1158\/1078-0432.CCR-17-0980","article-title":"MAPK pathway and TERT promoter gene mutation pattern and its prognostic value in melanoma patients: a retrospective study of 2,793 cases","volume":"23","author":"Bai","year":"2017","journal-title":"Clin Cancer Res."},{"key":"R25-20230908","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/cup.12323","article-title":"TERT promoter mutation is uncommon in acral lentiginous melanoma","volume":"41","author":"Liau","year":"2014","journal-title":"J Cutan Pathol."},{"key":"R26-20230908","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/CMR.0000000000000222","article-title":"Molecular profiling, including TERT promoter mutations, of acral lentiginous melanomas","volume":"26","author":"Vazquez Vde","year":"2016","journal-title":"Melanoma Res."},{"key":"R27-20230908","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1101\/gr.213348.116","article-title":"Integrated genomic analyses reveal frequent TERT aberrations in acral melanoma","volume":"27","author":"Liang","year":"2017","journal-title":"Genome Res."},{"key":"R28-20230908","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1056\/NEJMoa050092","article-title":"Distinct sets of genetic alterations in melanoma","volume":"353","author":"Curtin","year":"2005","journal-title":"N Engl J Med."},{"key":"R29-20230908","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jaad.2014.05.035","article-title":"TERT gene amplification is associated with poor outcome in acral lentiginous melanoma","volume":"71","author":"Diaz","year":"2014","journal-title":"J Am Acad Dermatol."},{"key":"R30-20230908","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/pcmr.12500","article-title":"High TERT promoter mutation frequency in non-acral cutaneous metastatic melanoma","volume":"29","author":"Ekedahl","year":"2016","journal-title":"Pigment Cell Melanoma Res."},{"key":"R31-20230908","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jaad.2015.10.003","article-title":"Lack of TERT promoter mutations in melanomas with extensive regression","volume":"74","author":"de Unamuno Bustos","year":"2016","journal-title":"J Am Acad Dermatol."},{"key":"R32-20230908","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00428-015-1784-x","article-title":"Coexistence of TERT promoter and BRAF mutations in cutaneous melanoma is associated with more clinicopathological features of aggressiveness","volume":"467","author":"Macerola","year":"2015","journal-title":"Virchows Arch."},{"key":"R33-20230908","first-page":"203","article-title":"Measures of diagnostic accuracy: basic definitions","volume":"19","author":"Simundic","year":"2009","journal-title":"EJIFCC."}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000372-201904000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T05:23:17Z","timestamp":1694150597000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000372-201904000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000001259","relation":{},"ISSN":["0193-1091"],"issn-type":[{"value":"0193-1091","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]}}}